Danny Gilad Allouche - Mar 1, 2025 Form 4 Insider Report for Avery Dennison Corp (AVY)

Role
SVP, CSDO & Interim CFO
Signature
/s/ Vikas Arora, attorney-in-fact for Danny Gilad Allouche
Stock symbol
AVY
Transactions as of
Mar 1, 2025
Transactions value $
$232,703
Form type
4
Date filed
3/4/2025, 06:54 PM
Previous filing
Nov 21, 2024
Next filing
Apr 2, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVY Common Stock Options Exercise $70.3K +376 +2.02% $187.06 19K Mar 1, 2025 Trust
transaction AVY Common Stock Tax liability -$31.6K -169 -0.89% $187.06 18.8K Mar 1, 2025 Trust
transaction AVY Common Stock Options Exercise $85.7K +458 +2.43% $187.06 19.3K Mar 1, 2025 Trust
transaction AVY Common Stock Tax liability -$37.8K -202 -1.05% $187.06 19.1K Mar 1, 2025 Trust
transaction AVY Common Stock Options Exercise $64.5K +345 +1.81% $187.06 19.4K Mar 1, 2025 Trust
transaction AVY Common Stock Tax liability -$30.9K -165 -0.85% $187.06 19.2K Mar 1, 2025 Trust
transaction AVY Common Stock Options Exercise $43.6K +233 +1.21% $187.06 19.5K Mar 1, 2025 Trust
transaction AVY Common Stock Tax liability -$16.1K -86 -0.44% $187.06 19.4K Mar 1, 2025 Trust
transaction AVY Common Stock Options Exercise $152K +811 +4.18% $187.06 20.2K Mar 1, 2025 Trust
transaction AVY Common Stock Tax liability -$66.8K -357 -1.77% $187.06 19.8K Mar 1, 2025 Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVY 2025 MSU Award Award $0 +2.46K $0.00 2.46K Mar 1, 2025 Common Stock 2.46K $0.00 Direct F1
transaction AVY 2025 PU Award Award $0 +2.56K $0.00 2.56K Mar 1, 2025 Common Stock 2.56K $0.00 Direct F2
transaction AVY 2025 Promotion RSU Award Award $0 +2.67K $0.00 2.67K Mar 1, 2025 Common Stock 2.67K $0.00 Direct F3
transaction AVY 2021 MSU Award Options Exercise $0 -376 -100% $0.00 0 Mar 1, 2025 Common Stock 376 $0.00 Direct F4
transaction AVY 2022 MSU Award Options Exercise $0 -458 -49.19% $0.00 473 Mar 1, 2025 Common Stock 458 $0.00 Direct F5
transaction AVY 2023 MSU Award Options Exercise $0 -345 -33.14% $0.00 696 Mar 1, 2025 Common Stock 345 $0.00 Direct F6
transaction AVY 2024 MSU Award Options Exercise $0 -233 -23.9% $0.00 742 Mar 1, 2025 Common Stock 233 $0.00 Direct F7
transaction AVY 2022 PU Award Options Exercise $0 -811 -100% $0.00 0 Mar 1, 2025 Common Stock 811 $0.00 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Market-leveraged stock units (MSUs) vest 25% over one-, two-, three- and four-year performance periods, with the number of shares paid on each vesting date based on our absolute total stockholder return. Each MSU represents a contingent right to receive one share of common stock, plus dividend equivalents accrued during the vesting period.
F2 Performance units (PUs) vest, at the end of fiscal year 2027, provided certain performance objectives are met as determined by the Compensation Committee in February 2028. Each PU represents a contingent right to receive one share of common stock.
F3 Restricted stock units (RSUs) cliff vest on the third anniversary of the grant date. Each RSU represents a contingent right to receive one share of common stock.
F4 Shares reflect the vesting of the fourth tranche of MSUs granted in February 2021 at 128% of target based on our absolute total stockholder return in excess of 10% during the 2021-2024 performance period, plus dividend equivalents accrued during the period.
F5 Shares reflect the vesting of the third tranche of MSUs granted in March 2022 at 92% of target based on our absolute total stockholder return during the 2022-2024 performance period, plus dividend equivalents accrued during the period.
F6 Shares reflect the vesting of the second tranche of MSUs granted in March 2023 at 96% of target based on our absolute total stockholder return during the 2023-2024 performance period, plus dividend equivalents accrued during the period.
F7 Shares reflect the vesting of the first tranche of MSUs granted in March 2024 at 93% of target based on our absolute total stockholder return during the 2024 performance period, plus dividend equivalents accrued during the period.
F8 Shares reflect the vesting of PUs granted in March 2022 at 50% of target, based 50% on our cumulative economic value added of 0% of target and 50% on our capped relative total stockholder return of 100% of target.